Zentalis Pharmaceuticals (ZNTL) Earnings Analysis
Zentalis Pharmaceuticals (ZNTL) has no confirmed upcoming earnings date. Last quarter (2026-03-26) it missed with EPS -0.49 USD vs -0.41 USD est (-19.5%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -2.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ZNTL next report earnings?
No confirmed upcoming earnings date is currently scheduled for ZNTL. This page updates as the calendar is published.
ZNTL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | -0.49 USD | -0.41 USD | -19.5% | Miss |
| 2025-11-10 | -0.37 USD | -0.49 USD | +24.5% | Beat |
| 2025-05-14 | -0.67 USD | -0.67 USD | 0% | Beat |
| 2024-08-09 | -1.24 USD | -0.83 USD | -49.4% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
ZNTL valuation and analyst view
| Trailing P/E | -2.60 |
|---|---|
| Trailing EPS | -1.76667 USD |
| Price / book | 1.73 |
| Dividend yield | 0.00% |
| Market cap | 0.31B |
| Analyst consensus | Buy (8 buy / 4 hold / 0 sell) |
| Avg price target | 10 USD |
Related research pages
Frequently asked questions
When is Zentalis Pharmaceuticals (ZNTL)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ZNTL. This page updates as the calendar is published.
Did ZNTL beat earnings last quarter?
In its 2026-03-26 report, ZNTL posted EPS of -0.49 USD versus a -0.41 USD estimate — a miss of 19.5%.
What is ZNTL's earnings track record?
Over the last 4 reported quarters with consensus data, ZNTL beat estimates 2 times (50%).
What is ZNTL's current P/E ratio and EPS?
ZNTL trades at a trailing P/E of -2.60 on trailing EPS of -1.7666657178640555 USD.
What do analysts rate ZNTL?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 10 USD.